Announcements

Solstice Advanced Materials Inc. (NASDAQ: SOLS) shows chief accounting officer Barresi John S with 15,992 derivative securities after transactions recorded on 10 September 2026. The reported holding follows awards made at $0 per share. Barresi’s listed position is chief accounting officer.

Smurfit Westrock plc (NYSE: SW) awarded Mayer Saverio 119 shares at $0 per share. Following the award, Saverio owned 241,684 shares. The award was dated September 10, 2026, and carried transaction code A.

Kairos Pharma, LTD. (AMEX: KAPA) issued a new investor presentation on September 14, 2026, for its participation in the H.C. Wainwright GlobalInvestmentConference in New York, NY. Chief Executive Officer John Yu presented the material as part of the company’s conference participation.

Smurfit Westrock plc (NYSE: SW) awarded Henao Alvaro 35 shares at $0 per share on September 10, 2026. The award was recorded under transaction code A.

Legend Biotech Corp (NASDAQ: LEGN) outlined a cell therapy pipeline spanning targets including Claudin 18.2, DLL3, GPRC5D and BCMA. The portfolio covers autologous, allogeneic and in vivo approaches, with CARVYKTI programs in patient follow-up or enrolling across newly diagnosed multiple myeloma settings.

Smurfit Westrock plc (NYSE: SW) awarded Chief Accounting Officer Page Irene 23 shares at $0 per share on September 10, 2026. The filing also reported 152 derivative securities awarded on the same date. Both entries carried SEC transaction code A.

LIGAND PHARMACEUTICALS INC (NASDAQ: LGND) director Zimmermann Martine sold 1,200 shares at $285 per share.